110 related articles for article (PubMed ID: 24266719)
1. Colon specific CODES based Piroxicam tablet for colon targeting: statistical optimization, in vivo roentgenography and stability assessment.
Singh AK; Pathak K
Pharm Dev Technol; 2015 Mar; 20(2):237-45. PubMed ID: 24266719
[TBL] [Abstract][Full Text] [Related]
2. Novel microbially triggered colon specific delivery system of 5-Fluorouracil: statistical optimization, in vitro, in vivo, cytotoxic and stability assessment.
Dev RK; Bali V; Pathak K
Int J Pharm; 2011 Jun; 411(1-2):142-51. PubMed ID: 21463667
[TBL] [Abstract][Full Text] [Related]
3. Inulin-based tablet in capsule device for variable multipulse delivery of aceclofenac: optimization and in vivo roentgenography.
Sharma P; Pathak K
AAPS PharmSciTech; 2013 Jun; 14(2):736-47. PubMed ID: 23615771
[TBL] [Abstract][Full Text] [Related]
4. Design of experiment approach for formulating multi-unit colon-targeted drug delivery system: in vitro and in vivo studies.
Shah N; Sharma OP; Mehta T; Amin A
Drug Dev Ind Pharm; 2016; 42(5):825-35. PubMed ID: 27019195
[TBL] [Abstract][Full Text] [Related]
5. Feasibility studies of concomitant administration of optimized formulation of probiotic-loaded Vancomycin hydrochloride pellets for colon delivery.
Avachat AM; Shinde AS
Drug Dev Ind Pharm; 2016 Jan; 42(1):80-90. PubMed ID: 25923416
[TBL] [Abstract][Full Text] [Related]
6. Risk Assessment and QbD-Based Optimization of Sorafenib Tosylate Colon Targeted Bilayer Tablet: In Vitro Characterization, In Vivo Pharmacokinetic, and In Vivo Roentgenography Studies.
Kenjale P; Pokharkar V
AAPS PharmSciTech; 2022 Jul; 23(6):184. PubMed ID: 35773598
[TBL] [Abstract][Full Text] [Related]
7. Formulation and Development of Novel Sulfasalazine Bilayer Tablets for The Treatment of Arthritis Associated With IBD: In-vitro and In-vivo Investigations.
Jadiya S; Upmanyu N; Sathiyanarayanan A; Jain V; Dubey R; Buwade P
J Pharm Sci; 2024 Jul; 113(7):1919-1926. PubMed ID: 38401631
[TBL] [Abstract][Full Text] [Related]
8. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
[TBL] [Abstract][Full Text] [Related]
9. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of dissolution behavior for a colon-specific drug delivery system (CODES) in multi-pH media using United States Pharmacopeia apparatus II and III.
Li J; Yang L; Ferguson SM; Hudson TJ; Watanabe S; Katsuma M; Fix JA
AAPS PharmSciTech; 2002; 3(4):E33. PubMed ID: 12916927
[TBL] [Abstract][Full Text] [Related]
11. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
Varum FJ; Hatton GB; Freire AC; Basit AW
Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
[TBL] [Abstract][Full Text] [Related]
12. Tabletted guar gum microspheres of piroxicam for targeted adjuvant therapy for colonic adenocarcinomas.
Vats A; Pathak K
Ther Deliv; 2012 Nov; 3(11):1281-95. PubMed ID: 23259249
[TBL] [Abstract][Full Text] [Related]
13. Bumadizone calcium dihydrate microspheres compressed tablets for colon targeting: formulation, optimization and in vivo evaluation in rabbits.
Nour SA; Abdelmalak NS; Naguib MJ
Drug Deliv; 2015 May; 22(3):286-97. PubMed ID: 24601826
[TBL] [Abstract][Full Text] [Related]
14. Formulation and development of release modulated colon targeted system of meloxicam for potential application in the prophylaxis of colorectal cancer.
Patel MM; Amin AF
Drug Deliv; 2011 May; 18(4):281-93. PubMed ID: 21138335
[TBL] [Abstract][Full Text] [Related]
15. Design, development and in vitro-in vivo study of a colon-specific fast disintegrating tablet.
Kshirsagar SJ; Bhalekar MR; Umap RR
Pharm Dev Technol; 2011 Oct; 16(5):449-56. PubMed ID: 20486875
[TBL] [Abstract][Full Text] [Related]
16. Design and optimization of colon-targeted system of theophylline for chronotherapy of nocturnal asthma.
Patel MM; Amin AF
J Pharm Sci; 2011 May; 100(5):1760-72. PubMed ID: 21154966
[TBL] [Abstract][Full Text] [Related]
17. Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease.
Patel MM; Amin AF
Pharm Dev Technol; 2013; 18(2):390-400. PubMed ID: 22304735
[TBL] [Abstract][Full Text] [Related]
18. Effect of casting solvent, film-forming agent and solubilizer on orodispersible films of a polymorphic poorly soluble drug: an
El-Bary AA; Al Sharabi I; Haza'a BS
Drug Dev Ind Pharm; 2019 Nov; 45(11):1751-1769. PubMed ID: 31416366
[TBL] [Abstract][Full Text] [Related]
19. Formulation and evaluation of floating tablet of H2-receptor antagonist.
Kesarla RS; Vora PA; Sridhar BK; Patel G; Omri A
Drug Dev Ind Pharm; 2015; 41(9):1499-511. PubMed ID: 25243639
[TBL] [Abstract][Full Text] [Related]
20. Development and in vitro characterization of mebendazole delayed release tablet for colonic drug delivery.
Baviskar D; Rajput A; Bare K; Biranwar Y; Chaudhari H; Narkhede D; Jain D
Pak J Pharm Sci; 2014 Mar; 27(2):249-53. PubMed ID: 24577910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
